ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meeting Abstracts
    • All Meetings
    • PRSYM 2026
    • ACR Convergence 2025
    • Download Abstract Supplements
  • Keyword Index
  • My Favorites
    • View & print my favorites
  • Search

Home » Meeting Abstracts » ACR/ARHP Annual Meeting 2017

Abstract Number: 485

Different Citrullination Profiles in Spontaneous Versus Leukemia-Associated Rheumatoid Arthritis

Tal Gazitt1, Son Hong Nguyen2, Ari Salinger2, Christian Lood3, Xizhang Sun1, Lena M. Tanaka1, David Feith4, Jeffrey Ledbetter5, Gordon Starkebaum6, Thomas Loughran Jr.7, Paul R. Thompson2 and Keith B. Elkon8, 1Division of Rheumatology, University of Washington, Seattle, WA, 2Biochemistry and Molecular Pharmacology, University of Massachusetts Medical School, Worcester, MA, 3Division of Rheumatology, Division of Rheumatology, Department of Medicine, University of Washington, Seattle, WA, 4Hematology and Oncology, University of Virginia, Charlottesville, VA, 5University of Washington, Seattle, WA, 6Department of Medicine, Division of Rheumatology, University of Washington, Seattle, WA, 7Hematology Oncology, University of Virginia, Charlottesville, VA, 8Division of Rheumatology, Department of Medicine, University of Washington, Seattle, WA

Share on X (Twitter) Share on Facebook Share on LinkedIn Share on Email
Print

Meeting: ACR/ARHP Annual Meeting 2017

Date of first publication: September 18, 2017

Keywords: citrullination, neutrophils and rheumatoid arthritis (RA)

Session Information

Date: Sunday, November 5, 2017

Title: Rheumatoid Arthritis – Human Etiology and Pathogenesis Poster I

Session Type: ACR Poster Session A

Session Time: 9:00AM-11:00AM

Background/Purpose:

Protein citrullination, the post-translational conversion of arginine to citrulline, mediated by peptidylarginine deiminase (PAD) enzymes, is considered a likely mechanism for the stimulation of anti-citrullinated protein antibodies (ACPA) in patients with rheumatoid arthritis (RA).  Hypercitrullination, the citrullination of multiple intracellular proteins, is seen in synovial fluid (SF) cells from RA patients. This unique form of citrullination is proposed to occur via immune-mediated, pore-forming membranolytic pathways such as perforin-granzyme activation.  Indeed, perforin and granzyme-producing CD8+ T effector cells are found in the synovium of pre-clinical RA patients as well as in the peripheral blood (PB) and SF of active RA patients, persisting into disease remission. 

Insight into the existence of potential cytotoxic mechanisms occurring in RA comes from the co-occurrence of RA in up to 36% of cases of T-cell Large Granular Lymphocyte (T-LGL) Leukemia, a clonal condition characterized by neutropenia attributed to the killing of neutrophils or their precursors by cytotoxic CD8+ T cells.   We thus queried LGL leukemia as a model for neutrophil (PMN)-directed cytotoxicity contributing to hypercitrullination and disease propagation in inflamed joints of ACPA+ RA patients. 

Methods:

The sera of 15 T-LGL leukemia patients (T-LGL), 19 T-LGL leukemia patients with co-existing RA (T-LGL/RA), and 4 healthy controls (HC) were analyzed for ACPA positivity by ELISA.  ACPA titers of each group of patients were compared using unpaired two-tailed T tests.  Neutrophils (PMN) from each of these groups were isolated from blood cells by density gradient centrifugation. Hypercitrullination of these cells (n=4/patient group) was compared with that of seropositive RA patients by proteomic analysis using Rhodamine-PG labeling, protein precipitation followed by Streptavidin enrichment, and sequent digestion. The resulting products were analyzed using LC-MS/MS on an LTQ-Orbitrap mass spectrometer. The tandem MS data were searched using SEQUEST algorithm using a concatenated target/decoy variant of the human and mouse International Protein Index database.    

 

Results:

T-LGL/RA patients had significantly higher serum ACPA positivity than T-LGL patients or HC (Fig. 1A). Surprisingly, however, the overall level of citrullinated proteins in PMN (Fig.1B) was not increased in T-LGL/RA compared to T-LGL patients, and was highest in PMN obtained from RA patients (Fig. 1B). 

 

 

 

 

 

 

Conclusion:

These results reveal an interesting dichotomy between RA that occurs spontaneously versus that occurring in patients with LGL leukemia. Whereas both spontaneous and LGL-associated RA develop high titer ACPA, only RA patients show a high degree of citrullination of neutrophil proteins. Whether this suggests a different source of immunogenic proteins or relates to other biologic processes, remains to be determined.   


Disclosure: T. Gazitt, None; S. H. Nguyen, None; A. Salinger, None; C. Lood, None; X. Sun, None; L. M. Tanaka, None; D. Feith, None; J. Ledbetter, None; G. Starkebaum, None; T. Loughran Jr., None; P. R. Thompson, None; K. B. Elkon, Celgene, 5,AstraZeneca, 5,Merck Human Health, 5,Resolve Therapeutic, 4,Amdax Therapeuti, 4.

To cite this abstract in AMA style:

Gazitt T, Nguyen SH, Salinger A, Lood C, Sun X, Tanaka LM, Feith D, Ledbetter J, Starkebaum G, Loughran T Jr., Thompson PR, Elkon KB. Different Citrullination Profiles in Spontaneous Versus Leukemia-Associated Rheumatoid Arthritis [abstract]. Arthritis Rheumatol. 2017; 69 (suppl 10). https://acrabstracts.org/abstract/different-citrullination-profiles-in-spontaneous-versus-leukemia-associated-rheumatoid-arthritis/. Accessed .

ACR Meeting Abstracts - https://acrabstracts.org/abstract/different-citrullination-profiles-in-spontaneous-versus-leukemia-associated-rheumatoid-arthritis/

My Favorites

Save and print abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract (must have cookies enabled in browser). See saved favorites.

Abstract Policies

  • ACR Convergence Abstract Embargo Policies
  • ACR Convergence Abstract Permissions & Reprints
  • PRSYM Abstract Policies

ACR Convergence. Where Rheumatology Meets

ACR Convergence 2026

Join us November 6-11 in Orlando, Florida.
See Registration Information

  • Contact ACR
  • Privacy Policy
  • ACR Policies
  • Cookie Preferences

© Copyright 2026 American College of Rheumatology